Infectious Disease Therapeutics Market 2027 By Drug Type, Disease Type, Distribution Channel, and Geography | The Insight Partners

Infectious Disease Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type (Anti-Bacterial, Anti-Viral, Anti-Parasite, Anti-Fungal); Disease Type (Bacterial, Viral, Fungal, Parasitic); Distribution Channel (Hospital and Retail Pharmacies, Independent Drug Stores, Online Pharmacies), and Geography

Report Code: TIPRE00016883 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Infectious diseases are caused by bacteria, viruses, parasites, or fungi. The infections caused by these microorganisms may or may not be contagious and result in mortality. The spread of disease is through skin contact, bodily fluids, airborne particles, and touching a surface touched by an infected person, resulting in a pandemic situation. Therefore, it is important to treat infectious disease at early stages.

MARKET DYNAMICS

The infectious disease therapeutics market growth is anticipated to grow due to rising incidences of infectious diseases, increasing demand for effective treatment, and growing investments for research and development for infectious disease therapeutics. The growing innovations and generic pharmaceutical products in developing regions are likely to serve growth opportunities for the market player in coming years.

MARKET SCOPE

The "Infectious Disease Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of infectious disease therapeutics market with detailed market segmentation by drug type, disease type and distribution channel. The infectious disease therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in infectious disease therapeutics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The infectious disease therapeutics market is segmented on the basis of, drug type, disease type and distribution channel. Based on drug type, the market is divided into anti-bacterial, anti-viral, anti-parasite, and anti-fungal. Based on disease type, the market is divided into bacterial, viral, fungal, and parasitic. And based on distribution channel, the market is classified as hospital and retail pharmacies, independent drug stores, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the infectious disease therapeutics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infectious disease therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting infectious disease therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infectious disease therapeutics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the infectious disease therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from infectious disease therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for infectious disease therapeutics in the global market. Below mentioned is the list of few companies engaged in the infectious disease therapeutics market.

The report also includes the profiles of key players in infectious disease therapeutics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Merck and Co., Inc.
  •  Novartis AG
  •  Pfizer, Inc.
  •  Boehringer Ingelheim GmbH
  •  AbbVie, Inc.
  •  F. Hoffmann-La Roche Ltd.
  •  Gilead Sciences
  •  GlaxoSmithKline plc
  •  AstraZeneca plc
  •  Bayer AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infectious Disease Therapeutics Market - By Drug Type
1.3.2 Infectious Disease Therapeutics Market - By Disease Type
1.3.3 Infectious Disease Therapeutics Market - By Distribution Channel
1.3.4 Infectious Disease Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFECTIOUS DISEASE THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFECTIOUS DISEASE THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFECTIOUS DISEASE THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFECTIOUS DISEASE THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. INFECTIOUS DISEASE THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INFECTIOUS DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTI-BACTERIAL
7.3.1. Overview
7.3.2. Anti-Bacterial Market Forecast and Analysis
7.4. ANTI-VIRAL
7.4.1. Overview
7.4.2. Anti-Viral Market Forecast and Analysis
7.5. ANTI-PARASITE
7.5.1. Overview
7.5.2. Anti-Parasite Market Forecast and Analysis
7.6. ANTI-FUNGAL
7.6.1. Overview
7.6.2. Anti-Fungal Market Forecast and Analysis
8. INFECTIOUS DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
8.1. OVERVIEW
8.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
8.3. BACTERIAL
8.3.1. Overview
8.3.2. Bacterial Market Forecast and Analysis
8.3.3. Urinary Tract Infection (UTI) Market
8.3.3.1. Overview
8.3.3.2. Urinary Tract Infection (UTI) Market Forecast and Analysis
8.3.4. Lyme Disease Market
8.3.4.1. Overview
8.3.4.2. Lyme Disease Market Forecast and Analysis
8.3.5. Tuberculosis Market
8.3.5.1. Overview
8.3.5.2. Tuberculosis Market Forecast and Analysis
8.3.6. Cellulitis Market
8.3.6.1. Overview
8.3.6.2. Cellulitis Market Forecast and Analysis
8.3.7. Bacterial Meningitis Market
8.3.7.1. Overview
8.3.7.2. Bacterial Meningitis Market Forecast and Analysis
8.3.8. Others Market
8.3.8.1. Overview
8.3.8.2. Others Market Forecast and Analysis
8.4. VIRAL
8.4.1. Overview
8.4.2. Viral Market Forecast and Analysis
8.4.3. Common Cold Market
8.4.3.1. Overview
8.4.3.2. Common Cold Market Forecast and Analysis
8.4.4. Measles Market
8.4.4.1. Overview
8.4.4.2. Measles Market Forecast and Analysis
8.4.5. Yellow Fever Market
8.4.5.1. Overview
8.4.5.2. Yellow Fever Market Forecast and Analysis
8.4.6. Dengue Fever Market
8.4.6.1. Overview
8.4.6.2. Dengue Fever Market Forecast and Analysis
8.4.7. HIV Market
8.4.7.1. Overview
8.4.7.2. HIV Market Forecast and Analysis
8.4.8. Others Market
8.4.8.1. Overview
8.4.8.2. Others Market Forecast and Analysis
8.5. FUNGAL
8.5.1. Overview
8.5.2. Fungal Market Forecast and Analysis
8.5.3. Vaginal Yeast Infection Market
8.5.3.1. Overview
8.5.3.2. Vaginal Yeast Infection Market Forecast and Analysis
8.5.4. Athlete's Foot Market
8.5.4.1. Overview
8.5.4.2. Athlete's Foot Market Forecast and Analysis
8.5.5. Ringworm Market
8.5.5.1. Overview
8.5.5.2. Ringworm Market Forecast and Analysis
8.5.6. Others Market
8.5.6.1. Overview
8.5.6.2. Others Market Forecast and Analysis
8.6. PARASITIC
8.6.1. Overview
8.6.2. Parasitic Market Forecast and Analysis
8.6.3. Trichomoniasis Market
8.6.3.1. Overview
8.6.3.2. Trichomoniasis Market Forecast and Analysis
8.6.4. Malaria Market
8.6.4.1. Overview
8.6.4.2. Malaria Market Forecast and Analysis
8.6.5. Intestinal Worms Market
8.6.5.1. Overview
8.6.5.2. Intestinal Worms Market Forecast and Analysis
8.6.6. Others Market
8.6.6.1. Overview
8.6.6.2. Others Market Forecast and Analysis
9. INFECTIOUS DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
9.4. INDEPENDENT DRUG STORES
9.4.1. Overview
9.4.2. Independent Drug Stores Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. INFECTIOUS DISEASE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Infectious Disease Therapeutics Market Overview
10.1.2 North America Infectious Disease Therapeutics Market Forecasts and Analysis
10.1.3 North America Infectious Disease Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America Infectious Disease Therapeutics Market Forecasts and Analysis - By Disease Type
10.1.5 North America Infectious Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Infectious Disease Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Infectious Disease Therapeutics Market
10.1.6.1.1 United States Infectious Disease Therapeutics Market by Drug Type
10.1.6.1.2 United States Infectious Disease Therapeutics Market by Disease Type
10.1.6.1.3 United States Infectious Disease Therapeutics Market by Distribution Channel
10.1.6.2 Canada Infectious Disease Therapeutics Market
10.1.6.2.1 Canada Infectious Disease Therapeutics Market by Drug Type
10.1.6.2.2 Canada Infectious Disease Therapeutics Market by Disease Type
10.1.6.2.3 Canada Infectious Disease Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Infectious Disease Therapeutics Market
10.1.6.3.1 Mexico Infectious Disease Therapeutics Market by Drug Type
10.1.6.3.2 Mexico Infectious Disease Therapeutics Market by Disease Type
10.1.6.3.3 Mexico Infectious Disease Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Infectious Disease Therapeutics Market Overview
10.2.2 Europe Infectious Disease Therapeutics Market Forecasts and Analysis
10.2.3 Europe Infectious Disease Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Infectious Disease Therapeutics Market Forecasts and Analysis - By Disease Type
10.2.5 Europe Infectious Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Infectious Disease Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Infectious Disease Therapeutics Market
10.2.6.1.1 Germany Infectious Disease Therapeutics Market by Drug Type
10.2.6.1.2 Germany Infectious Disease Therapeutics Market by Disease Type
10.2.6.1.3 Germany Infectious Disease Therapeutics Market by Distribution Channel
10.2.6.2 France Infectious Disease Therapeutics Market
10.2.6.2.1 France Infectious Disease Therapeutics Market by Drug Type
10.2.6.2.2 France Infectious Disease Therapeutics Market by Disease Type
10.2.6.2.3 France Infectious Disease Therapeutics Market by Distribution Channel
10.2.6.3 Italy Infectious Disease Therapeutics Market
10.2.6.3.1 Italy Infectious Disease Therapeutics Market by Drug Type
10.2.6.3.2 Italy Infectious Disease Therapeutics Market by Disease Type
10.2.6.3.3 Italy Infectious Disease Therapeutics Market by Distribution Channel
10.2.6.4 Spain Infectious Disease Therapeutics Market
10.2.6.4.1 Spain Infectious Disease Therapeutics Market by Drug Type
10.2.6.4.2 Spain Infectious Disease Therapeutics Market by Disease Type
10.2.6.4.3 Spain Infectious Disease Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Infectious Disease Therapeutics Market
10.2.6.5.1 United Kingdom Infectious Disease Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom Infectious Disease Therapeutics Market by Disease Type
10.2.6.5.3 United Kingdom Infectious Disease Therapeutics Market by Distribution Channel
10.2.6.6 Rest of Europe Infectious Disease Therapeutics Market
10.2.6.6.1 Rest of Europe Infectious Disease Therapeutics Market by Drug Type
10.2.6.6.2 Rest of Europe Infectious Disease Therapeutics Market by Disease Type
10.2.6.6.3 Rest of Europe Infectious Disease Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Infectious Disease Therapeutics Market Overview
10.3.2 Asia-Pacific Infectious Disease Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Infectious Disease Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Infectious Disease Therapeutics Market Forecasts and Analysis - By Disease Type
10.3.5 Asia-Pacific Infectious Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Infectious Disease Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Infectious Disease Therapeutics Market
10.3.6.1.1 Australia Infectious Disease Therapeutics Market by Drug Type
10.3.6.1.2 Australia Infectious Disease Therapeutics Market by Disease Type
10.3.6.1.3 Australia Infectious Disease Therapeutics Market by Distribution Channel
10.3.6.2 China Infectious Disease Therapeutics Market
10.3.6.2.1 China Infectious Disease Therapeutics Market by Drug Type
10.3.6.2.2 China Infectious Disease Therapeutics Market by Disease Type
10.3.6.2.3 China Infectious Disease Therapeutics Market by Distribution Channel
10.3.6.3 India Infectious Disease Therapeutics Market
10.3.6.3.1 India Infectious Disease Therapeutics Market by Drug Type
10.3.6.3.2 India Infectious Disease Therapeutics Market by Disease Type
10.3.6.3.3 India Infectious Disease Therapeutics Market by Distribution Channel
10.3.6.4 Japan Infectious Disease Therapeutics Market
10.3.6.4.1 Japan Infectious Disease Therapeutics Market by Drug Type
10.3.6.4.2 Japan Infectious Disease Therapeutics Market by Disease Type
10.3.6.4.3 Japan Infectious Disease Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Infectious Disease Therapeutics Market
10.3.6.5.1 South Korea Infectious Disease Therapeutics Market by Drug Type
10.3.6.5.2 South Korea Infectious Disease Therapeutics Market by Disease Type
10.3.6.5.3 South Korea Infectious Disease Therapeutics Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Infectious Disease Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Infectious Disease Therapeutics Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Infectious Disease Therapeutics Market by Disease Type
10.3.6.6.3 Rest of Asia-Pacific Infectious Disease Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Infectious Disease Therapeutics Market Overview
10.4.2 Middle East and Africa Infectious Disease Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Infectious Disease Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Infectious Disease Therapeutics Market Forecasts and Analysis - By Disease Type
10.4.5 Middle East and Africa Infectious Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Infectious Disease Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Infectious Disease Therapeutics Market
10.4.6.1.1 South Africa Infectious Disease Therapeutics Market by Drug Type
10.4.6.1.2 South Africa Infectious Disease Therapeutics Market by Disease Type
10.4.6.1.3 South Africa Infectious Disease Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Infectious Disease Therapeutics Market
10.4.6.2.1 Saudi Arabia Infectious Disease Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia Infectious Disease Therapeutics Market by Disease Type
10.4.6.2.3 Saudi Arabia Infectious Disease Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Infectious Disease Therapeutics Market
10.4.6.3.1 U.A.E Infectious Disease Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E Infectious Disease Therapeutics Market by Disease Type
10.4.6.3.3 U.A.E Infectious Disease Therapeutics Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Infectious Disease Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Infectious Disease Therapeutics Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Infectious Disease Therapeutics Market by Disease Type
10.4.6.4.3 Rest of Middle East and Africa Infectious Disease Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Infectious Disease Therapeutics Market Overview
10.5.2 South and Central America Infectious Disease Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Infectious Disease Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Infectious Disease Therapeutics Market Forecasts and Analysis - By Disease Type
10.5.5 South and Central America Infectious Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Infectious Disease Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Infectious Disease Therapeutics Market
10.5.6.1.1 Brazil Infectious Disease Therapeutics Market by Drug Type
10.5.6.1.2 Brazil Infectious Disease Therapeutics Market by Disease Type
10.5.6.1.3 Brazil Infectious Disease Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Infectious Disease Therapeutics Market
10.5.6.2.1 Argentina Infectious Disease Therapeutics Market by Drug Type
10.5.6.2.2 Argentina Infectious Disease Therapeutics Market by Disease Type
10.5.6.2.3 Argentina Infectious Disease Therapeutics Market by Distribution Channel
10.5.6.3 Rest of South and Central America Infectious Disease Therapeutics Market
10.5.6.3.1 Rest of South and Central America Infectious Disease Therapeutics Market by Drug Type
10.5.6.3.2 Rest of South and Central America Infectious Disease Therapeutics Market by Disease Type
10.5.6.3.3 Rest of South and Central America Infectious Disease Therapeutics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INFECTIOUS DISEASE THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. MERCK AND CO., INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NOVARTIS AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BOEHRINGER INGELHEIM GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ABBVIE, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F. HOFFMANN-LA ROCHE LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GILEAD SCIENCES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GLAXOSMITHKLINE PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ASTRAZENECA PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BAYER AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck and Co., Inc.
2. Novartis AG
3. Pfizer, Inc.
4. Boehringer Ingelheim GmbH
5. AbbVie, Inc.
6. F. Hoffmann-La Roche Ltd.
7. Gilead Sciences
8. GlaxoSmithKline plc
9. AstraZeneca plc
10. Bayer AG
TIPRE00016883
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking